Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines

Chikungunya virus (CHIKV) is an alphavirus associated with a broad tissue tropism for which no antivirals or vaccines are approved. This study evaluated the antiviral potential of favipiravir (FAV), interferon-alpha (IFN), and ribavirin (RBV) against CHIKV as mono- and combination-therapy in cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Evelyn J., Tao, Xun, Hanrahan, Kaley C., Zhou, Jieqiang, Bulitta, Jürgen B., Brown, Ashley N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912990/
https://www.ncbi.nlm.nih.gov/pubmed/33540830
http://dx.doi.org/10.3390/microorganisms9020307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912990/
https://www.ncbi.nlm.nih.gov/pubmed/33540830
http://dx.doi.org/10.3390/microorganisms9020307

Ejemplares similares